Global Medical Radioactive Microspheres Market Strategic Research Report
By Type: Holmium-166 Microspheres, Yttrium-90 Microspheres
By Application: Cancer Treatment, Diagnosis, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: New Radiomedicine Technology, Grand Pharmaceutical Group Limited, YH Nu-Med, Boston Scientific, Sirtex Medical Limited, Terumo, ABK Biomedical, AtomVie, BWXT Medical
Обзор
Scope of the Report
The global Medical Radioactive Microspheres market size is predicted to grow from US$ 208 million in 2025 to US$ 444 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032.
Medical radioactive microspheres are a type of radioactive embolic agent that uses interventional means to inject micron-sized particles (usually 20-45 microns in diameter) containing radionuclides (such as yttrium [90Y]) into the tumor's blood supply artery. The carrier material is mostly ceramic, resin or glass. It releases beta rays through targeted tumors (to kill tumor cells at close range, and at the same time has the function of embolizing blood vessels, which can significantly improve the local control rate of tumors and reduce normal tissue damage. It is mainly used clinically for the treatment of solid tumors such as primary liver cancer and colorectal cancer liver metastasis that cannot be surgically removed. It has the advantages of high targeting, few side effects, and reliable efficacy, and can meet individualized treatment needs through customized personalized activity.
Future development trends, driving factors and obstacles of medical radioactive microspheres
Application field expansion
At present, medical radioactive microspheres are mainly used for liver cancer treatment, but in the future they are expected to be expanded to the treatment of other malignant tumors such as pancreatic cancer, bladder cancer, head and neck cancer, etc. In addition, with the advancement of technology, radioactive microspheres may play a greater role in the treatment of benign diseases.
Technological innovation and product upgrade
The preparation technology of radioactive microspheres will continue to be optimized, such as developing microspheres with smaller particle size and more uniform distribution to improve the treatment effect and reduce side effects. At the same time, the research on visual microspheres will promote the development of real-time monitoring technology, enabling doctors to control the distribution and dosage of microspheres more accurately.
Intensified market competition
As market demand grows, more and more companies will enter the field of medical radioactive microspheres, and market competition will become more intense. At present, major global manufacturers include Sirtex Medical and Boston Scientific Corporation, and more new players may emerge in the future.
Development drivers
Increasing cancer incidenc
The global cancer incidence rate is increasing year by year, especially malignant tumors such as liver cancer. According to the World Health Organization, liver cancer is the sixth most common cancer in the world and the third leading cause of cancer death. As an effective local treatment method, the market demand for radioactive microspheres will continue to grow.
Technological progress
The preparation technology and application technology of radioactive microspheres are constantly improving. For example, the research and application of yttrium [90Y] microspheres make treatment more accurate and safe. In addition, the research on visualized microspheres will further improve the controllability and effect of treatment.
Policy support
Governments of various countries have continuously increased their support for medical technology, especially in the field of cancer treatment. For example, China has introduced a series of policies to support the development of biopharmaceuticals and traditional Chinese medicine industries, and promote the industrialization of technologies such as sustained-release preparations and targeted preparations.
Development obstacles
Technical barriers
The preparation technology of medical radioactive microspheres is complex and requires high-precision equipment and processes. At present, domestic companies still have a certain gap in microsphere preparation technology, relying on imported materials and equipment, which increases production costs and supply chain uncertainty.
Market competition and price pressure
With the intensification of market competition, price pressure will increase. How to reduce production costs and improve market competitiveness while ensuring product quality and efficacy is a challenge faced by companies.
Regulation and approval
As medical devices, medical radioactive microspheres need to undergo strict supervision and approval. Different regulatory requirements in different countries and regions increase the difficulty and time cost of bringing products to market.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Radioactive Microspheres market?
What factors are driving Medical Radioactive Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Radioactive Microspheres market opportunities vary by end market size?
How does Medical Radioactive Microspheres break out by Type, by Application?
This report presents a comprehensive overview of the global Medical Radioactive Microspheres market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Holmium-166 Microspheres
- Yttrium-90 Microspheres
Segment by Application
- Cancer Treatment
- Diagnosis
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Medical Radioactive Microspheres market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Cancer Treatment, Diagnosis, Others evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Medical Radioactive Microspheres Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Holmium-166 Microspheres
- 3.1.3 Yttrium-90 Microspheres
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Cancer Treatment
- 4.1.3 Diagnosis
- 4.1.4 Others
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 New Radiomedicine Technology
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Grand Pharmaceutical Group Limited
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 YH Nu-Med
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Boston Scientific
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Sirtex Medical Limited
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Terumo
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 ABK Biomedical
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 AtomVie
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 BWXT Medical
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Medical Radioactive Microspheres market?
How fast is the Medical Radioactive Microspheres market expected to grow?
What does the Medical Radioactive Microspheres market cover?
What are the main segments of the Medical Radioactive Microspheres market by type?
Which applications drive demand in the Medical Radioactive Microspheres market?
Who are the key players in the Medical Radioactive Microspheres market?
Which regions and countries are covered for Medical Radioactive Microspheres?
What is driving growth in the Medical Radioactive Microspheres market?
What challenges does the Medical Radioactive Microspheres market face?
Who should buy the Medical Radioactive Microspheres market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Medical Radioactive Microspheres Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices